SYMBIOTEC Quarterly Results, Profit & Loss, Balance Sheet (SYMBIOTEC)

SYMBIOTEC quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • SYMBIOTEC Financials
  • SYMBIOTEC Shareholding Pattern
  • SYMBIOTEC Earnings Documents
  • SYMBIOTEC Announcements
  • SYMBIOTEC Corporate Actions
  • SYMBIOTEC Bulk, Block & Insider Deals
  • SYMBIOTEC Delivery Data
  • SYMBIOTEC Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Symbiotec Pharmalab Ltd (SYMBIOTEC) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Symbiotec Pharmalab Ltd reported sales of ₹218 Cr, operating profit of ₹45 Cr (OPM 21%) and net profit of ₹14 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.

SYMBIOTEC quarterly results (₹ Cr)
MetricJun 2025Mar 2026Jun 2026
Sales203245218
Expenses145183173
Operating Profit586245
OPM29%25%21%
Other Income300
Interest576
Depreciation112022
Profit before tax453518
Tax33%22%20%
Net Profit302814
EPS in Rs46.994.392.24
SYMBIOTEC profit & loss, annual (₹ Cr)
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales633682567716752869
Expenses438550497544549630
Operating Profit19513170172203239
OPM31%19%12%24%27%27%
Other Income73674-6
Interest73881726
Depreciation222629394353
Profit before tax17310539132147153
Tax28%27%38%23%34%28%
Net Profit123782310097110
EPS in Rs112.7270.8921.4891.49151.9817.51
Dividend Payout0%0%0%0%0%0%
SYMBIOTEC balance sheet (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital1111111113
Reserves5886117048041,137
Borrowings65218247544391
Other Liabilities152151326220240
Total Liabilities8159901,2891,5801,781
Fixed Assets2802994484381,120
CWIP4018220856864
Investments55414
Other Assets490504628572592
Total Assets8159901,2891,5801,781
SYMBIOTEC cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity186918847175
Cash from Investing Activity-32-220-206-307-227
Cash from Financing Activity151462227836
Net Cash Flow1-5319-16
Free Cash Flow-55-155-22-261-50
CFO/OP36%124%129%40%99%
SYMBIOTEC ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days7772648583
Inventory Days252305382321274
Days Payable91110259109160
Cash Conversion Cycle238267187298197
Working Capital Days12110776-3-22
ROCE18%6%16%14%13%
  • SYMBIOTEC Shareholding Pattern
  • SYMBIOTEC Earnings Concalls
  • SYMBIOTEC Growth Catalysts
  • SYMBIOTEC Corporate Actions
  • SYMBIOTEC Announcements
  • SYMBIOTEC Results & Documents
  • SYMBIOTEC Bulk & Block Deals
  • SYMBIOTEC Delivery Data